- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Hannover, Gottfried Wilhelm Leibniz Universität, Dissertation, 2023
- Keyword
-
Proteine
Peptide
- Event
-
Veröffentlichung
- (where)
-
Hannover
- (who)
-
Gottfried Wilhelm Leibniz Universität
- (when)
-
2024
- Creator
-
Englmaier, Felix
- DOI
-
10.15488/14435
- URN
-
urn:nbn:de:101:1-2406060207106.834311848074
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek.
If you have any questions about the object, please contact the data provider.
Associated
- Englmaier, Felix
- Gottfried Wilhelm Leibniz Universität
Time of origin
- 2024
Other Objects (12)
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
Targeting CDK9 for anti-cancer therapeutics
Targeting ferroptosis in melanoma: cancer therapeutics
Developing inhaled protein therapeutics for lung diseases
Highway to Success—Developing Advanced Polymer Therapeutics
Immunogenicity Risk Assessment for Multi-specific Therapeutics
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
miR-34a regulates adipogenesis in porcine intramuscular adipocytes by targeting ACSL4
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Deciphering the Molecular Mechanisms of Cancer and Developing Precision Therapeutics
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
Targeting CDK9 for anti-cancer therapeutics
Targeting ferroptosis in melanoma: cancer therapeutics
Developing inhaled protein therapeutics for lung diseases
Highway to Success—Developing Advanced Polymer Therapeutics
Immunogenicity Risk Assessment for Multi-specific Therapeutics
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
miR-34a regulates adipogenesis in porcine intramuscular adipocytes by targeting ACSL4
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Deciphering the Molecular Mechanisms of Cancer and Developing Precision Therapeutics
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
Targeting CDK9 for anti-cancer therapeutics
Targeting ferroptosis in melanoma: cancer therapeutics
Developing inhaled protein therapeutics for lung diseases
Highway to Success—Developing Advanced Polymer Therapeutics
Immunogenicity Risk Assessment for Multi-specific Therapeutics
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
miR-34a regulates adipogenesis in porcine intramuscular adipocytes by targeting ACSL4
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics